Control group:Neoadjuvant chemotherapy

4 trials

Sponsors

China-Japan Friendship Hospital, Shanghai Pulmonary Hospital, Shenzhen Second People's Hospital, Xinqiao Hospital, Third Military Medical University

Conditions

Non-small cell lung cancer (NSCLC)breast cancerlung cancer

Early Phase 1

Clinical study of immunotherapy combined with chemotherapy for postoperative adjuvant therapy of stage II-IIIA non-small cell lung cancer

Active, not recruitingChiCTR2100050439

China-Japan Friendship HospitalNon-small cell lung cancer (NSCLC)

Start: 2021-10-11Updated: 2022-05-02

Phase 2

Phase II randomized controlled study of the efficacy and safety of neoadjuvant chemotherapy combined with endocrine therapy in Luminal B1 (HR+) breast cancer at high risk of recurrence

Active, not recruitingChiCTR2300072950

Shenzhen Second People's Hospitalbreast cancer

Start: 2023-07-01Updated: 2023-07-02

Phase 4

Recombinant Human Adenovirus Type 5 Combined with Neoadjuvant Chemotherapy for Stage III Lung Cancer: A Prospective, Randomized Controlled Trial

RecruitingChiCTR2200055779

Shanghai Pulmonary Hospitallung cancer

Start: 2022-01-20Updated: 2023-06-26

Unknown Phase

The Enhancement of the neoadjuvant Chemotherapy of Breast Cancer Combined Ultrasound and Microbubbles

RecruitingChiCTR-INR-17010680

Xinqiao Hospital, Third Military Medical Universitybreast cancer

Start: 2016-09-01Updated: 2017-04-18